New
Genetic Technologies Limited
The AI engine Fit Assessment
BetaGenetic Technologies is dedicated to advancing women's health through personalized risk assessments and comprehensive genetic testing solutions.
Blurb
Genetic Technologies is a molecular diagnostics company that offers molecular risk assessment for cancer.
HQ Location
Fitzroy (Australia)
Founded
1987
Employees
51 - 200
Total funding raised
$13.10M
Last Funding Event
Post-IPO Equity, $5.10M, July 20, 2020
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Genomic and Genetic Testing
Genetic Technologies is a biotechnology research company. They offer medical diagnostic and sequencing services include medical, forensic, paternity and animal genomic testing, enabling physicians and doctors to get correct data for treatment of the patients.